*Greenwich Hospital, Yale University Medical School, Greenwich, Connecticut; †Wilkes Regional Medical Center, North Wilkesboro, North Carolina; ‡Presbyterian Hospital, Columbia University College of Physicians and Surgeons, New York, New York, U.S.A.
Inflamm Bowel Dis. 1997 Fall;3(3):217-24.
: Extraintestinal manifestations of inflammatory bowel disease (IBD) are common. Clinically significant renal/urologic complications occur in 10-15% of patients with IBD. In this article, we review the incidence, pathogenesis, diagnosis, and management of the various renal/urologic complications. In general, renal/urologic complications in IBD may be directly related to the underlying intestinal disease process (acalculous hydronephrosis, fistula formation, abscess) related to metabolic consequences of the disease (urolithiasis) or to the medication used in the treatment of IBD. Less clearly understood complications include amyloidosis and glomerular disease. Renal/urologic complications of IBD represent a potential source of significant morbidity and mortality. Clinicians caring for patients with IBD should therefore be familiar with the various manifestations of these complications, as well as appropriate preventative measures and treatment.
炎症性肠病(IBD)的肠外表现较为常见。临床上有 10-15%的 IBD 患者会出现有意义的肾/泌尿道并发症。本文综述了各种肾/泌尿道并发症的发生率、发病机制、诊断和治疗。一般来说,IBD 的肾/泌尿道并发症可能与潜在的肠道疾病过程(无结石性肾积水、瘘管形成、脓肿)、疾病的代谢后果(尿路结石)或用于治疗 IBD 的药物直接相关。不太清楚的并发症包括淀粉样变性和肾小球疾病。IBD 的肾/泌尿道并发症是严重发病率和死亡率的潜在来源。因此,照顾 IBD 患者的临床医生应该熟悉这些并发症的各种表现,以及适当的预防措施和治疗方法。